Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Various source-derived mesenchymal stem cells (MSCs) have been considered for cell therapeutics in incurable diseases. To characterize MSCs from different sources, we compared human bone marrow (BM), adipose tissue (AT), and umbilical cord blood-derived MSCs (UCB-MSCs) for surface antigen expression, differentiation ability, proliferation capacity, clonality, tolerance for aging, and paracrine activity. Although MSCs from different tissues have similar levels of surface antigen expression, immunosuppressive activity, and differentiation ability, UCB-MSCs had the highest rate of cell proliferation and clonality, and significantly lower expression of p53, p21, and p16, well known markers of senescence. Since paracrine action is the main action of MSCs, we examined the anti-inflammatory activity of each MSC under lipopolysaccharide (LPS)-induced inflammation. Co-culture of UCB-MSCs with LPS-treated rat alveolar macrophage, reduced expression of inflammatory cytokines including interleukin-1α (IL-1α), IL-6, and IL-8 via angiopoietin-1 (Ang-1). Using recombinant Ang-1 as potential soluble paracrine factor or its small interference RNA (siRNA), we found that Ang-1 secretion was responsible for this beneficial effect in part by preventing inflammation. Our results demonstrate that primitive UCB-MSCs have biological advantages in comparison to adult sources, making UCB-MSCs a useful model for clinical applications of cell therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedDominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 11×
“[23] concluded that AT is suitable as it contains MSCs at the highest frequency and UCB as it seems to be expandable to higher numbers.”
InfluentialMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“Mechanistic evidence of the benefits of MSCs has been based on their paracrine effect, controlling inflammation or promoting regeneration via soluble factors [19,20].”
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine
Caplan, A. I. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21200 · Cited by 1,956 · cited 1×
“Mesenchymal stem cells (MSCs) possess self-renewal and multi-lineage differentiation potentials, and are thus an attractive source of stem cells for tissue engineering [1,2].”
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344 · cited 1×
“In addition, senescence can be trigged by p53 and its downstream target p21, followed by activation of p16 [26,27].”
Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process
Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002213 · Cited by 1,129
Ortiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019
Cited by
Mesenchymal Stem Cells for Regenerative Medicine
Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., & Ding, J. (2019) · Cells · doi:10.3390/cells8080886 · Cited by 1,093
Mesenchymal stem cells: Cell therapy and regeneration potential
Brown, C., McKee, C., Bakshi, S., Walker, K., Hakman, E., Halassy, S., Svinarich, D., Dodds, R., Govind, C. K., & Chaudhry, G. R. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2914 · Cited by 609
Mazini, L., Rochette, L., Amine, M., & Malka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102523 · Cited by 445
Li, C.-Y., Wu, X.-Y., Tong, J.-B., Yang, X.-X., Zhao, J.-L., Zheng, Q.-F., Zhao, G.-B., & Ma, Z.-J. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0066-5 · Cited by 410
“Both BMMSCs and ATMSCs reveal very similar expression patterns of surface markers in agreement with the FBS-based comparative phenotypic analysis described earlier [40,41].”
GRANGE, C., TAPPARO, M., BRUNO, S., CHATTERJEE, D., QUESENBERRY, P. J., TETTA, C., & CAMUSSI, G. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1663 · Cited by 361
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., Veronesi, E., Horwitz, E. M., & Dominici, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0044 · Cited by 350
Anisotropic Materials for Skeletal‐Muscle‐Tissue Engineering
Jana, S., Levengood, S. K. L., & Zhang, M. (2016) · Advanced Materials · doi:10.1002/adma.201600240 · Cited by 345
Bone tissue regeneration: biology, strategies and interface studies
Ansari, M. (2019) · Progress in Biomaterials · doi:10.1007/s40204-019-00125-z · Cited by 340
Hu, Y., Tao, R., Chen, L., Xiong, Y., Xue, H., Hu, L., Yan, C., Xie, X., Lin, Z., Panayi, A. C., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00894-5 · Cited by 328
Mattar, P., & Bieback, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00560 · Cited by 300
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Jovic, D., Yu, Y., Wang, D., Wang, K., Li, H., Xu, F., Liu, C., Liu, J., & Luo, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10369-1 · Cited by 286
Adult Stem Cells for Bone Regeneration and Repair
Iaquinta, M. R., Mazzoni, E., Bononi, I., Rotondo, J. C., Mazziotta, C., Montesi, M., Sprio, S., Tampieri, A., Tognon, M., & Martini, F. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00268 · Cited by 259
Markov, A., Thangavelu, L., Aravindhan, S., Zekiy, A. O., Jarahian, M., Chartrand, M. S., Pathak, Y., Marofi, F., Shamlou, S., & Hassanzadeh, A. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02265-1 · Cited by 257
RetractedMesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential
Volarevic, V., Gazdic, M., Simovic Markovic, B., Jovicic, N., Djonov, V., & Arsenijevic, N. (2017) · BioFactors · doi:10.1002/biof.1374 · Cited by 195
“In contrast to BM-MSCs and AT-MSCs, UCBMSCs have the highest rates of cell proliferation and clonality and significantly lower expression of p53, p21, and p16, well known markers of senescence [9,10].”
BackgroundAhn, S. Y., Chang, Y. S., Sung, S. I., & Park, W. S. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0219 · Cited by 170
Human Adipose Stem Cells: From Bench to Bedside
De Francesco, F., Ricci, G., D'Andrea, F., Nicoletti, G. F., & Ferraro, G. A. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0608 · Cited by 163
Lv, X., Liu, Y., Song, S., Tong, C., Shi, X., Zhao, Y., Zhang, J., & Hou, M. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.10.067 · Cited by 136
Kriebel, K., Hieke, C., Müller-Hilke, B., Nakata, M., & Kreikemeyer, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00053 · Cited by 118
“Stem cells can be isolated from various adult tissues, including bone marrow and gingiva (Barry and Murphy, 2004; Sonoyama et al., 2006; Tavian et al., 2006; Zhang et al., 2009; Jin et al., 2013).”
BackgroundLiu, W., Liu, A., Li, X., Sun, Z., Sun, Z., Liu, Y., Wang, G., Huang, D., Xiong, H., Yu, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.012 · Cited by 107
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
Cao, Y., Ji, C., & Lu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.119 · Cited by 99
“MSCs from different sources are found to exhibit similar phenotypes as defined by ISCT minimum criteria (18), yet there were some differences in the proliferation capacity, differentiation potential, levels of paracrine factors, and immunomodulatory properties (19-21).”
BackgroundCurrent understanding of mesenchymal stem cells in liver diseases
Wu, M.-C., & Meng, Q.-H. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i9.1349 · Cited by 29
Pessôa, L. V. D. F., Pires, P. R. L., del Collado, M., Pieri, N. C. G., Recchia, K., Souza, A. F., Perecin, F., da Silveira, J. C., de Andrade, A. F. C., Ambrosio, C. E., et al. (2019) · Stem Cells International · doi:10.1155/2019/1393791 · Cited by 29
Yarahmadi, A., Dorri Giv, M., Hosseininejad, R., Rezaie, A., Mohammadi, N., Afkhami, H., & Farokhi, A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1472679 · Cited by 21
Hamilton, A. M., Foster, P. J., & Ronald, J. A. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.111 · Cited by 17
Zafarvahedian, E., Roohi, A., Sepand, M. R., Ostad, S. N., & Ghahremani, M. H. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3289 · Cited by 8
“The UC‐MSCs can be easily isolated, can give large yields, and are independent to donor age and free from ethical complications.(7) Besides, there are concerns about how”
Background
Metadata
- Authors
- Jin, H., Bae, Y., Kim, M., Kwon, S.-J., Jeon, H., Choi, S., Kim, S., Yang, Y., Oh, W., & Chang, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2013-09-03
- Volume
- 14
- Issue
- 9
- Pages
- 17986-18001
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2156509094
- Cited by
- 663
- References
- 44
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.